Quick Takeaways
- EGRX - EAGLE PHARMACEUTICALS, INC. has 10 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 10 Insiders of EAGLE PHARMACEUTICALS, INC.
- Symbol
- EGRX on OTC
- Location
- Woodcliff Lake, NJ
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 16 Apr 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
EAGLE PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Scott Tarriff | 10%+ Owner | $9,111,840 | Mixed | 28 Feb 2024 | ||
| Brian Joseph Cahill | Chief Financial Officer | $308,850 | Mixed | 27 Feb 2024 | ||
| Michael Shawn Moran | EVP, Chief Commercial Officer | $164,750 | Mixed | 28 Feb 2022 | ||
| Michael Graves | Interim Executive Chair & PEO, Director | $53,147 | Mixed | 21 Dec 2023 | ||
| Robert Glenning | Director | Mixed | 07 Mar 2023 | |||
| Christopher Krawtschuk | Chief Financial Officer | Mixed | 11 Nov 2024 | |||
| Richard A. Edlin | Director | Mixed | 07 Mar 2023 | |||
| Steven B. Ratoff | Director | Mixed | 07 Mar 2023 | |||
| Luciana Borio | Director | Mixed | 07 Mar 2023 | |||
| Jennifer K. Simpson | Director | Mixed | 07 Mar 2023 |
Top shareholders of EAGLE PHARMACEUTICALS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13D/G
|
— |
38%
|
4,945,209
|
$14,341,106 | $0 | 30 Jun 2025 | |
| Scott Tarriff |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,453,244
|
$9,111,840 | — | 28 Feb 2024 | |
| Union Square Park Capital Management, LLC |
13D/G
|
Union Square Park Partners, LP |
11%
|
1,485,677
|
$2,911,927 | $0 | 31 Dec 2024 | |
| J. Goldman & Co LP |
13D/G
|
— |
5.1%
|
667,108
|
$1,934,613 | $0 | 30 Jun 2025 | |
| Nantahala Capital Partners Limited Partnership |
13D/G
|
— |
6.2%
|
810,630
|
$1,588,835 | $0 | 16 Feb 2025 | |
| Brian Joseph Cahill |
3/4/5
|
CHIEF FINANCIAL OFFICER |
—
class O/S missing
|
47,958
|
$308,850 | — | 27 Feb 2024 | |
| Michael Shawn Moran |
3/4/5
|
EVP, Chief Commercial Officer |
—
class O/S missing
|
32,115
|
$164,750 | — | 28 Feb 2022 | |
| Michael Graves |
3/4/5
|
Interim Executive Chair & PEO, Director |
—
mixed-class rows
|
303,360
mixed-class rows
|
$53,147 | — | 21 Dec 2023 | |
| Stanley-Laman Group, Ltd. |
13F
|
Company |
0.09%
|
12,000
|
$8,400 | — | 31 Dec 2025 | |
| Archer Investment Corp |
13F
|
Company |
0%
|
350
|
$245 | — | 31 Dec 2025 | |
| Jennifer K. Simpson |
3/4/5
|
Director |
—
class O/S missing
|
16,253
|
— | — | 07 Mar 2023 | |
| Luciana Borio |
3/4/5
|
Director |
—
class O/S missing
|
16,253
|
— | — | 07 Mar 2023 | |
| Richard A. Edlin |
3/4/5
|
Director |
—
class O/S missing
|
16,253
|
— | — | 07 Mar 2023 | |
| Robert Glenning |
3/4/5
|
Director |
—
class O/S missing
|
16,253
|
— | — | 07 Mar 2023 | |
| Steven B. Ratoff |
3/4/5
|
Director |
—
class O/S missing
|
16,253
|
— | — | 07 Mar 2023 |
Recent Insider Transactions by Companies or Individuals for EAGLE PHARMACEUTICALS, INC.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.